Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with bone disease severity in Rett syndrome

BACKGROUND: More than 95% of individuals with RTT have mutations in methyl-CpG-binding protein 2 (MECP2), whose protein product modulates gene transcription. The disorder is caused by mutations in a single gene and the disease severity in affected individuals can be quite variable. Specific MECP2 mu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Med Genet
Asıl Yazarlar: Caffarelli, Carla, Gonnelli, Stefano, Pitinca, Maria Dea Tomai, Camarri, Silvia, Al Refaie, Antonella, Hayek, Joussef, Nuti, Ranuccio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6995101/
https://ncbi.nlm.nih.gov/pubmed/32005172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12881-020-0960-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller